Pfizer’s $43 Billion Bet: Understanding the Rise of ‘Turbo Cancers’ Introduction In a shocking move, pharmaceutical giant Pfizer has acquired Seagen, a small drug company specializing in treating “turbo cancers.” This $43 billion deal has left many puzzled. Why would Pfizer, already making massive profits from its mRNA vaccine, invest such a significant amount in … Continue reading Shocking Revelation: Pfizer’s $43 Billion Gamble and the Truth About Turbo Cancers Linked to mRNA Vaccines